shows evidence of dysfunction of the blood-brain barrier and inflammation in the central nervous system in individuals with Down syndrome Regression Disorder (DSRD). CDKL5, one of the five members ...

Simufilam did not show a significant reduction in co-primary endpoints of cognitive or functional decline versus placebo in ...

How alcohol-induced plasticity evolves over protracted abstinence is not well understood. Here, authors show the long-lasting impact of drinking on dopamine transmission and that altered function ...

Learn how nanoparticles cross the blood-brain barrier (BBB) and explore their potential in treating neurological disorders ...

GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...

As health officials continue to issue warnings about the dangers of alcohol, it might be time to ditch the nightly habit.

Retinal neurodegenerative diseases, such as inherited retinal dystrophies, age-related macular degeneration, glaucoma and ...

"In contrast, very few neurons in the central nervous system itself expressed Cdkl," Kanca said ... Borja, Stephanie Bivona, Undiagnosed Diseases Network, Baylor College of Medicine Center for ...

It attacks the central nervous system and 99% of the cases are caused ... It prevents the infection from spreading to the nervous system. Dr. Sanket Mankad, Infectious Diseases Consultant, Shalby ...

InTandem Capital Partners ("InTandem Capital" or the "Firm"), a healthcare services-focused private equity firm, announced today that it has partnered with the founder and management team at Clinilabs ...

Neurological disorders affect the function of the nervous system. Common pediatric neurological disorders include ADHD, autism spectrum disorder, epilepsy, and cerebral palsy. Neurological ...